REFERENCES
- Lacour M, Rudolphi U, Schlesier M et al, Type 2 collagen-specific human T cell lines established from healthy donors, Eur J Immunol 20, 931 (1990).
- Ota K, Matsui M, Milford EL et al, T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis, Nature 346, 183 (1990).
- Burns J, Rozenzweig A, Zweiman B et al, Isolation of myelin basic protein-reactive T-cell lines from normal human blood, Cell Immunol 81, 435 (1983).
- Genain CP, Lee-Parritz D, Nguyen MH et al, In healthy primates, circulating autoreactive T cells mediate autoimmune disease, J Clin Invest 94, 1339 (1994).
- Lanoue A, Bona C, Boehmer H et al, Conditions that induce tolerance in mature CD4+ T cells, ./Exp Med 185, 405 (1997).
- Dayan CM, Chu NR, Londei M et al, T cells involved in human autoimmune disease are resistant to tolerance induction, J Immunol 151, 1606 (1993).
- Ogawa N, Dang H, Talal N, Apoptosis and autoimmunity, J Autoimmunity 8, 1 (1995).
- Russell JH, White CL, Loh DY et al, Receptor-stimulated death pathway is opened by antigen in mature T cells, Proc Natl Acad Sei USA 88, 2151 (1991).
- Dhein J, Walczak H, Baumler C et al, Autocrine T-cell suicide mediated by APO-1 (Fas/CD95), Nature 373, 438 (1995).
- Ju S-T, Panka DJ, Cui H et al, Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation, Nature 373, 444 (1995).
- Alderson MR, Tough TW, Davis-Smith T et al, Fas ligand mediates activation-induced cell death in human T lymphocytes, J Exp Med 181, 71 (1995).
- Brunner T, Mogil RJ, LaFace D et al, Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas, Nature 373, 441 (1995).
- Zheng L, Fisher G, Miller RE et al, Induction of apoptosis in mature T cells by tumor necrosis factor, Nature 111, 348 (1995).
- Russell JH, Rush B, Weaver C et al, Mature T cells of autoimmune Iprllpr mice have a defect in antigen-stimulated suicide, Proc Natl Acad Sci USA 90, 4409 (1993).
- Russell JH, Wang R, Autoimmune g Id mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells, Eur J Immunol 23, 2379 (1993).
- Lenardo MJ, Interleukin-2 programs mouse aft T lymphocytes for apoptosis, Nature 353, 858 (1991).
- Fournel S, Genestier L, Robinet E et al, Human T cells require IL-2 but not G] /S transition to acquire susceptibility to Fas-mediated apoptosis, J Immunol 157, 4309 (1996).
- Sadlack B, Lohler J, Schorle H et al, Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells, Eur J Immunol 25,3053(1995).
- Willerford DM, Chen J, Ferry JA et al, Interleukin-2 receptor a chain regulates the size and content of the peripheral lymphoid compartment, Immunity 3, 521 (1995).
- Parijs LV, Biuckians A, Ibragimov A et al, Functional responses and apoptosis of CD25 (IL-2Ra)-deficient T cells expressing a transgenic antigen receptor, J Immunol 158, 3738 (1997).
- Glickstein LJ, Huber BT, Karoushi — Death by overwork in the immune system, J Immunol 155,522(1995).
- Talal N, Moutsopoulos HM, Kassan SS (Eds), Sjogren’s Syndrome: Clinical and Immunological Aspects. Springer-Verlag, Berlin, (1987).
- Gerii R, Gertotto A, Agea E et al., Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sjogren’s syndrome, J Clin Invest 86, 1870 (1990).
- Miyasaka N, Murota N, Yamaoka K et al, Interleukin 2 defect in the peripheral blood and the lung in patients with Sjogren’s syndrome, Clin Exp Immunol 65, 497 (1986).
- Ogawa N, Dang H, Kong L et al, Lymphocyte apoptosis and apoptosis-associated gene expression in Sjogren’s syndrome (SS) patients, Arthritis Rheum 39, 1875 (1996).
- Ohashi H, Ogawa N, Goto Y et al, Elevated Fas (CD95) and Bcl-2 protein expression on T cells from patients with primary Sjogren’s syndrome, Arthritis Rheum 39, S288 (1996).
- Kong L, Ogawa N, Nakabayashi T et al, Fas and Fas ligand expression in salivary glands of patients with primary Sjogren’s syndrome, Arthritis Rheum 40, 87 (1996).
- Vitali C, Bombardieri S, Moutsopoulos HM et al, Preliminary criteria for the classification of Sjogren’s syndrome. Results from a prospective concerted action supported by the European Community, Arthritis Rheum 36, 340 (1993).
- Ogawa N, Itoh M, Goto Y, Abnormal production of B cell growth factor in patients with systemic lupus erythematosus, Clin Exp Immunol 89, 26 (1992).
- Ogawa N, Dang H, Lazaridis K et al, Analysis of transforming growth factor-fi and other cytokines in autoimmune exocrinopathy (Sjogren’s syndrome), J Interferon Cytokine Res 15, 759(1995).
- Varadhachary AS, Perdow SN, Hu C et al, Differential ability of T cell subsets to undergo activation-induced cell death, Proc Natl Acad Sci USA 94, 5778 (1997).
- Trauth BC, Klas C, Peters AMJ et al, Monoclonal antibody-mediated tumor regression by induction of apoptosis, Science 245, 301 (1989).
- Suda T, Okazaki T, Naito Y et al, Expression of the Fas ligand in cells of T cell lineage, J Immunol 154, 3806(1995).
- Sumida T, Matsumoto I, Murata H et al, TCR in Fas-sensitive T cells from labial salivary glands of patients with Sjogren’s syndrome, J Immunol 158, 1020 (1997).
- Seki M, Ushiyama C, Seta N et al, Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus eryhtematosus, Arthritis Rheum 41, 823(1998).